Thomas Wakim
Stock Analyst at Bell Potter
(0.36)
# 4,458
Out of 5,014 analysts
115
Total ratings
43.4%
Success rate
-7.3%
Average return
Main Sectors:
Stocks Rated by Thomas Wakim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: ALC Alcidion Group Limited | Reiterated: Buy | $0.15 | $0.11 | +42.86% | 16 | Sep 30, 2026 | |
| ASX: IMM Immutep Limited | Reiterated: Hold | $0.07 → $0.06 | $0.03 | +81.82% | 9 | Sep 14, 2026 | |
| ASX: PYC PYC Therapeutics Limited | Reiterated: Buy | $2.30 → $3.00 | $2.53 | +18.81% | 9 | Sep 14, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Downgraded: Hold | $17.00 → $11.50 | $8.34 | +37.89% | 6 | Aug 27, 2026 | |
| ASX: NEU Neuren Pharmaceuticals Limited | Reiterated: Buy | $25.50 | $20.10 | +26.87% | 17 | Aug 27, 2026 | |
| ASX: CGS Cogstate Limited | Reiterated: Buy | $3.70 | $3.36 | +10.12% | 7 | Aug 19, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $120.00 → $150.00 | $178.88 | -16.14% | 11 | Aug 19, 2026 | |
| ASX: ATX Amplia Therapeutics Limited | Reiterated: Buy | $0.42 | $0.12 | +265.22% | 3 | Aug 5, 2026 | |
| ASX: SNT Syntara Limited | Reiterated: Buy | $0.06 | $0.02 | +185.71% | 7 | Jul 28, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Downgraded: Hold | $0.12 → $0.05 | $0.05 | +4.17% | 13 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.55 → $0.10 | $0.08 | +28.21% | 8 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.09 → $0.10 | $0.01 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.30 → $0.05 | $0.01 | n/a | 4 | Apr 1, 2025 |
Alcidion Group Limited
Sep 30, 2026
Reiterated: Buy
Price Target: $0.15
Current: $0.11
Upside: +42.86%
Immutep Limited
Sep 14, 2026
Reiterated: Hold
Price Target: $0.07 → $0.06
Current: $0.03
Upside: +81.82%
PYC Therapeutics Limited
Sep 14, 2026
Reiterated: Buy
Price Target: $2.30 → $3.00
Current: $2.53
Upside: +18.81%
Clinuvel Pharmaceuticals Limited
Aug 27, 2026
Downgraded: Hold
Price Target: $17.00 → $11.50
Current: $8.34
Upside: +37.89%
Neuren Pharmaceuticals Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $25.50
Current: $20.10
Upside: +26.87%
Cogstate Limited
Aug 19, 2026
Reiterated: Buy
Price Target: $3.70
Current: $3.36
Upside: +10.12%
CSL Limited
Aug 19, 2026
Reiterated: Hold
Price Target: $120.00 → $150.00
Current: $178.88
Upside: -16.14%
Amplia Therapeutics Limited
Aug 5, 2026
Reiterated: Buy
Price Target: $0.42
Current: $0.12
Upside: +265.22%
Syntara Limited
Jul 28, 2026
Reiterated: Buy
Price Target: $0.06
Current: $0.02
Upside: +185.71%
Microba Life Sciences Limited
Jul 16, 2026
Downgraded: Hold
Price Target: $0.12 → $0.05
Current: $0.05
Upside: +4.17%
Apr 7, 2026
Downgraded: Hold
Price Target: $0.55 → $0.10
Current: $0.08
Upside: +28.21%
May 13, 2025
Reiterated: Hold
Price Target: $0.09 → $0.10
Current: $0.01
Upside: n/a
Apr 1, 2025
Downgraded: Sell
Price Target: $1.30 → $0.05
Current: $0.01
Upside: n/a